The firm said it will use the money, from new investor Technology Partners and existing backer Foundry Group, to fund a global expansion and develop a bio-sensory in-home panel, which EmSense said would be the first of its kind.

EmSense president and CEO Keith Winter said: “We are especially pleased to welcome Technology Partners as well-respected investors and valued partners as EmSense enters a period of very rapid growth.”

Technology Partners is led by Roger Quy (pictured), who Winters said “may be one of the only venture capitalists with a PhD in neuroscience and a research background in neurotechnology”.

“As such,” said Winters, “he is particularly well-suited to advise our company.”

Quy added: “We believe that neuromarketing is now mainstream and is poised for explosive growth. Over the past year we conducted extensive diligence on the neuromarketing space and chose EmSense based on their highly-scalable business model, numerous clients and key market research partners.”